SU‐E‐T‐591: Optimizing Quality Assurance in a Prospective Phase II Clinical Trial for Intermediate‐Risk Prostate Cancer with Brachytherapy as Monotherapy Using a Paladium‐103 Standed‐Seed Nomogram

R. Kudchadker, Thomas Pugh, T. Bruno, W. du, D. Swanson, S. Frank

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'SU‐E‐T‐591: Optimizing Quality Assurance in a Prospective Phase II Clinical Trial for Intermediate‐Risk Prostate Cancer with Brachytherapy as Monotherapy Using a Paladium‐103 Standed‐Seed Nomogram'. Together they form a unique fingerprint.

Medicine & Life Sciences